{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:59:02Z","timestamp":1790114342537,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":254,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013420","name":"Tsumura and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.curtheres.2020.100605","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:20:35Z","timestamp":1600168835000},"page":"100605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study"],"prefix":"10.1016","volume":"93","author":[{"given":"Ken-ichi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Hirono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kitahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2020.100605_bib0001","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.curtheres.2020.100605_bib0002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djz073","article-title":"Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis","volume":"111","author":"Janssen","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.curtheres.2020.100605_bib0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.curtheres.2020.100605_bib0004","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.curtheres.2020.100605_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.21873\/anticanres.11389","article-title":"Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer","volume":"37","author":"Okada","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.curtheres.2020.100605_bib0006","doi-asserted-by":"crossref","first-page":"66226","DOI":"10.18632\/oncotarget.19887","article-title":"Bitter Melon Extract Inhibits Breast Cancer Growth in Preclinical Model by Inducing Autophagic Cell Death","volume":"8","author":"Muhammad","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.curtheres.2020.100605_bib0007","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1940-6207.CAPR-17-0046","article-title":"Bitter Melon Enhances Natural Killer-Mediated Toxicity Against Head and Neck Cancer Cells","volume":"10","author":"Bhattacharya","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.curtheres.2020.100605_bib0008","doi-asserted-by":"crossref","first-page":"33202","DOI":"10.18632\/oncotarget.8898","article-title":"Immunomodulatory Role of Bitter Melon Extract in Inhibition of Head and Neck Squamous Cell Carcinoma Growth","volume":"7","author":"Bhattacharya","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.curtheres.2020.100605_bib0009","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.3748\/wjg.v11.i26.4013","article-title":"Herbal medicine Ninjinyoeito ameliorates ribavirin-induced anemia in chronic hepatitis C: a randomized controlled trial","volume":"11","author":"Motoo","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.curtheres.2020.100605_bib0010","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1567-5769(03)00101-2","article-title":"Effect of a traditional Chinese herbal medicine, Ren-Shen-Yang-Rong-Tang (Japanese name: Ninjin-Youei-To), on oligodendrocyte precursor cells from aged-rat brain","volume":"3","author":"Kobayashi","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.curtheres.2020.100605_bib0011","unstructured":"TSUMURA Ninjin'yoeito Extract Granules for Ethical Use. Revised: March 2013 (6th version). https:\/\/www.tsumura.co.jp\/english\/products\/pi\/JPR_T108.pdf."},{"key":"10.1016\/j.curtheres.2020.100605_bib0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnut.2018.00072","article-title":"Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study","volume":"5","author":"Ito","year":"2018","journal-title":"Front Nutr"},{"key":"10.1016\/j.curtheres.2020.100605_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/jmf.2013.3071","article-title":"Omija fruit extract improves endurance and energy metabolism by upregulating PGC-1\u03b1 expression in the skeletal muscle of exercised rats","volume":"17","author":"Kim","year":"2014","journal-title":"J Med Food"},{"key":"10.1016\/j.curtheres.2020.100605_bib0014","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijbiomac.2016.08.042","article-title":"Metabolic mechanism of a polysaccharide from Schisandra chinensis to relieve chronic fatigue syndrome","volume":"93","author":"Chi","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.curtheres.2020.100605_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jep.2014.02.027","article-title":"Identification of a novel anti-inflammatory compound, \u03b1-cubebenoate from Schisandra chinensis","volume":"153","author":"Kang","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.curtheres.2020.100605_bib0016","first-page":"121","article-title":"Prospective validation of patient fatigue questionnaire (FACIT-F) for fatigue assessment in nab-paclitaxel plus gemcitabine therapy","volume":"8","author":"Okada","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.curtheres.2020.100605_bib0017","first-page":"1355","article-title":"Brief versions of the FACIT\u2013fatigue and FAACT subscales for patients with non\u2013small cell lung cancer cachexia","volume":"23","author":"Salsman","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.curtheres.2020.100605_bib0018","first-page":"1483","article-title":"Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02","volume":"17","author":"Shimozuma","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.curtheres.2020.100605_bib0019","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology, pancreatic adenocarcinoma-Version 2.2016. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/pancreatic.pdf."},{"key":"10.1016\/j.curtheres.2020.100605_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40169-015-0051-8","article-title":"Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression","volume":"4","author":"Cruz","year":"2015","journal-title":"Clin Transl Med"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X2030031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X2030031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:59:01Z","timestamp":1757897941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X2030031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"alternative-id":["S0011393X2030031X"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2020.100605","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Ninjin'Yoeito on Fatigue in Patients Receiving Nab-Paclitaxel Plus Gemcitabine Therapy: A Prospective, Single-Arm, Phase II Open Label, Nonrandomized, Historically-Controlled Study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2020.100605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100605"}}